Vascular Solutions To Be Acquired By Teleflex Incorporated

Ad

overcome challenges

How Small Manufacturers Can Overcome Challenges on Their Way to Profit

The current government has taken welcome steps to improve the business environment in India. Through Make in India, it also continues to give manufacturing a much-needed push. However, banking on the government for business improvement...

Ad

What Are The Various Benefits Of Availing Small Business...

Small business owners often get in a situation where they require an additional funding source for their business. And in situations like this, small business loans are the saviour for them. There are many lenders...

Vascular Solutions, Inc. (Nasdaq:VASC) today announced that it has entered into a definitive agreement to be acquired by Teleflex Incorporated (NYSE:TFX) for a purchase price of $56.00 per share in cash.

The transaction implies an equity purchase price of $1.0 billion. Upon completion of the transaction, Vascular Solutions will become a wholly owned subsidiary of Teleflex.

The purchase price represents a 16% premium over Vascular Solutions’ average closing price during the 90 trading days ended December 1, 2016.

In addition, the purchase price is 38.4x the midpoint of the company’s preliminary 2017 EPS guidance of $1.44 to $1.48, and the transaction value, net of cash on hand, is 5.2x the midpoint of the company’s preliminary 2017 revenue guidance of $183 million to $187 million.

Howard Root, CEO of Vascular Solutions, provided the following comments: “As our Board discussed the future of Vascular Solutions, we determined that now is the time for the right partner to take over our successful and growing business. Following the jury verdict in February vindicating Vascular Solutions and me, I took some time to consider what I want to do next and what risks I want to continue to assume.”

“At the end of that process, I concluded that, while I still love Vascular Solutions 20 years after I started the company, I am not willing to assume much longer the personal risk associated with being the CEO of a public medical device company. Given the resulting uncertainty in the future leadership of our company, the Board believed it was in the best interests of our shareholders to evaluate alternatives to Vascular Solutions continuing as a stand-alone public company.” he added.

He further added “As the Board completed its thorough evaluation process, we unanimously became convinced that the proposed acquisition by Teleflex is in the best interests of our shareholders, and that Teleflex is the right partner for our employees and our customers to continue to grow our business, both clinically and professionally, for many years to come.”

The transaction is expected to close in the first half of 2017, subject to customary closing conditions, including approval by Vascular Solutions’ shareholders and the receipt of certain regulatory approvals.

The transaction has been unanimously approved by the Board of Directors of both companies and is not subject to any financing condition.  Teleflex will fund the transaction through the proceeds from one or more debt financing transactions.

So, what are your thoughts on this story?
Tell us in the comments.

Boost Your Knowledge. Subscribe & Learn Everything about the Indian Startup Ecosystem

Adid Khan
Hello! I am Adid Khan, a marketer, entrepreneur, travel junkie and foodie. I love travelling, meeting new people, eating and eating. My journey started as a hacker.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Download Premium WordPress Themes Free
Download Best WordPress Themes Free Download
Download WordPress Themes
Free Download WordPress Themes
udemy paid course free download
download coolpad firmware
Download Nulled WordPress Themes

Receive Daily Funding Updates

SUBSCRIBE
Close

WANNA SUBSCRIBE

GET DAILY UPDATES ABOUT THE STARTUP ECOSYSTEM
I AM IN
* Terms & Conditions Apply
close-link